Ultime notizie per TMX Group (OTC:TMXXF) Azioni

TMX Group Ltd is a company that operates several markets to provide investment opportunities for its clients. Company has four operating segments: Global Solutions, Insights & Analytics, Capital Formation, Derivatives Trading & Clearing, and Equities and Fixed Income Trading & Clearing. Maximum of it revenue is from Global Solutions, Insights & Analytics which deliver equities data, index data as well as integrated data sets to fuel high value proprietary and third party analytics which help clients make trading and investment decisions. Company geographically operates in Canada, USA, UK, Germany and Other Countries, with maximum revenue from Canada.

TMX Group Ltd

Seaport Entertainment (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/SEG#AMEX">SEG</a>) reported quarterly losses of $(1.79) per share. This is a 71.45 percent increase over losses of $(6.27) per share from the same period last year. The company reported $16.07 million in sales this quarter. This is a 10.74 percent increase over sales of $14.51 million the same period last year.

Earnings

News

Seaport Entertainment Q1 Adj. EPS $(1.79) Up From $(6.27) YoY, Sales $16.07M Up From $14.51M YoY

Amtech Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASYS#NASDAQ">ASYS</a>) sees Q3 sales of $16.000 million-$19.000 million vs $18.50 million analyst estimate.

Guidance

ASYS

Amtech Systems Sees Q3 Sales $16.000M-$19.000M vs $18.50M Est

~ William P. Foley, II, appointed as Vice Chairman of the Board ~
~ Doug Ammerman appointed Chairman of the Board ~
~ Ryan Caswell appointed Chief Executive Officer ~
~ Expands Relationship with JANA Partners, Broadening Cannae's Ability to Allocate Capital to Proprietary Acquisition and Investment Opportunities ~
~ Appoints Two New Independent Directors with Significant Investment &amp; Governance Experience to Enhance Strategy ~
~ Declassifying the Board ~
~ Reiterates Commitment to Strategy for Long-Term Value Creation ~
Cannae Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNNE#NYSE">CNNE</a>) ("Cannae" or the "Company") today announced that the Company's Board of Directors (the "Board") has approved a series of strategic actions designed to unlock shareholder value; including diversifying the Company's portfolio; broadening its capital allocation opportunities and appointing two new independent directors to its Board with significant investment and governance experience. In addition, the Board announced an executive management succession, details of which are below.

Management

CNNE

Cannae Holdings Appoint Doug Ammerman As Chairman Of The Board & Ryan Caswell As CEO. Company Also Expands Relationship With JANA Partners

<a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.repay.com%2F&amp;esheet=54253223&amp;newsitemid=20250512240628&amp;lan=en-US&amp;anchor=Repay+Holdings+Corporation&amp;index=1&amp;md5=783b6ffe0ac9efd3ad9030dc0a71d354">Repay Holdings Corporation</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RPAY#NASDAQ">RPAY</a>) ("REPAY" or the "Company"), a leading provider of integrated payment processing solutions, today announced that its Board of Directors has increased its authorized share repurchase program. The share repurchase program authorizes the Company to now purchase up to $75 million (up from $50 million) of the Company's Class A common stock. As of the date of this release, there remains approximately $61.2 million in capacity for share repurchases under the increased share repurchase program.

Buybacks

RPAY

REPAY  Authorizes The Company To Now Purchase Up To $75M, Up From $50M, Of The Company's Class A Common Stock

Earnings Beats

ARCT

Arcturus Therapeutics Q1 EPS $(0.52) Beats $(1.33) Estimate, Sales $29.38M Beat $27.88M Estimate

Integral Ad Science Holdi (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IAS#NASDAQ">IAS</a>) raises FY2025 sales outlook from $588.00 million-$600.00 million to $590.00 million-$600.00 million vs $592.02 million estimate.

Integral Ad Science Holdi Raises FY2025 Sales Guidance from $588.00M-$600.00M to $590.00M-$600.00M vs $592.02M Est

Amtech Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASYS#NASDAQ">ASYS</a>) reported quarterly losses of $(0.16) per share. This is a 1500 percent decrease over losses of $(0.01) per share from the same period last year. The company reported quarterly sales of $15.58 million which missed the analyst consensus estimate of $18.50 million by 15.78 percent. This is a 38.74 percent decrease over sales of $25.43 million the same period last year.

Earnings Misses

Amtech Systems Q2 Adj. EPS $(0.16) Down From $(0.01) YoY, Sales $15.58M Miss $18.50M Estimate

Vinci Partners Inv (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VINP#NASDAQ">VINP</a>) reported quarterly earnings of $0.17 per share which met the analyst consensus estimate. This is a 5.56 percent decrease over earnings of $0.18 per share from the same period last year. The company reported quarterly sales of $39.55 million which missed the analyst consensus estimate of $41.78 million by 5.33 percent. This is a 83.30 percent increase over sales of $21.58 million the same period last year.

VINP

Vinci Partners Inv Q1 Adj. EPS $0.17, Inline, Sales $39.55M Miss $41.78M Estimate

Peraso (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRSO#NASDAQ">PRSO</a>) sees Q2 sales of $1.800 million-$2.000 million vs $3.81 million analyst estimate.

PRSO

Peraso Sees Q2 Sales $1.800M-$2.000M vs $3.81M Est

Integral Ad Science Holdi (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IAS#NASDAQ">IAS</a>) sees Q2 sales of $142.000 million-$144.000 million vs $129.18 million analyst estimate.

Integral Ad Science Holdi Sees Q2 Sales $142.000M-$144.000M vs $129.18M Est

Peraso (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRSO#NASDAQ">PRSO</a>) reported quarterly losses of $(0.08) per share which beat the analyst consensus estimate of $(0.16) by 50 percent. This is a 90.36 percent increase over losses of $(0.83) per share from the same period last year. The company reported quarterly sales of $3.87 million which beat the analyst consensus estimate of $3.81 million by 1.67 percent. This is a 37.39 percent increase over sales of $2.82 million the same period last year.

Peraso Q1 Adj. EPS $(0.08) Beats $(0.16) Estimate, Sales $3.87M Beat $3.81M Estimate

Integral Ad Science (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IAS#NASDAQ">IAS</a>) reported quarterly earnings of $0.05 per share which beat the analyst consensus estimate of $0.03 by 66.67 percent. This is a 600 percent increase over losses of $(0.01) per share from the same period last year. The company reported quarterly sales of $134.07 million which beat the analyst consensus estimate of $129.18 million by 3.78 percent. This is a 17.06 percent increase over sales of $114.53 million the same period last year.

Integral Ad Science Q1 EPS $0.05 Beats $0.03 Estimate, Sales $134.07M Beat $129.18M Estimate

American Public Education (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APEI#NASDAQ">APEI</a>) affirms FY2025 sales outlook from $650.00 million-$660.00 million to $650.00 million-$660.00 million vs $654.04 million estimate.

APEI

American Public Education Affirms FY2025 Sales Guidance of $650.00M-$660.00M vs $654.04M Est

American Public Education (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APEI#NASDAQ">APEI</a>) is looking for Q2 GAAP EPS of $(0.13)-$(0.04) vs $0.15 analyst estimate. sees sales of $160.000 million-$162.000 million vs $161.73 million analyst estimate.

American Public Education Sees Q2 GAAP EPS $(0.13)-$(0.04) vs $0.15 Est; Sees Sales $160.000M-$162.000M vs $161.73M Est

Karyopharm Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KPTI#NASDAQ">KPTI</a>) affirms FY2025 sales outlook from $140.00 million-$155.00 million to $140.00 million-$155.00 million vs $149.32 million estimate.

KPTI

Karyopharm Therapeutics Affirms FY2025 Sales Guidance of $140.00M-$155.00M vs $149.32M Est

Ampco-Pittsburgh (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AP#NYSE">AP</a>) reported quarterly earnings of $0.06 per share. This is a 142.86 percent increase over losses of $(0.14) per share from the same period last year. The company reported $104.27 million in sales this quarter. This is a 5.40 percent decrease over sales of $110.22 million the same period last year.

Ampco-Pittsburgh Q1 EPS $0.06 Up From $(0.14) YoY, Sales $104.27M Down From $110.22M YoY

PennantPark Floating Rate (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PFLT#NYSE">PFLT</a>) reported quarterly earnings of $0.28 per share which missed the analyst consensus estimate of $0.32 by 12.5 percent. This is a 9.68 percent decrease over earnings of $0.31 per share from the same period last year. The company reported quarterly sales of $61.94 million which missed the analyst consensus estimate of $62.89 million by 1.52 percent. This is a 39.64 percent increase over sales of $44.35 million the same period last year.

PFLT

PennantPark Floating Rate Q2 Adj. EPS $0.28 Misses $0.32 Estimate, Sales $61.94M Miss $62.89M Estimate

VSEE

VSee Health Receives Nasdaq Notice Regarding Delayed Form 10-K Filing

Energy Vault Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NRGV#NYSE">NRGV</a>) reported quarterly losses of $(0.14) per share which missed the analyst consensus estimate of $(0.13) by 7.69 percent. This is unchanged from the same period last year. The company reported quarterly sales of $8.53 million which missed the analyst consensus estimate of $25.04 million by 65.92 percent. This is a 9.99 percent increase over sales of $7.76 million the same period last year.

NRGV

Energy Vault Holdings Q1 EPS $(0.14) Misses $(0.13) Estimate, Sales $8.53M Miss $25.04M Estimate

Ascent Industries (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACNT#NASDAQ">ACNT</a>) reported quarterly losses of $(0.10) per share. This is a 75.61 percent increase over losses of $(0.41) per share from the same period last year. The company reported $24.73 million in sales this quarter. This is a 43.93 percent decrease over sales of $44.11 million the same period last year.

Comments

TMX Group

Notizie

Ultime notizie per TMX Group (OTC:TMXXF) Azioni

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO